WO2012072670A3 - Slimming compositions - Google Patents

Slimming compositions Download PDF

Info

Publication number
WO2012072670A3
WO2012072670A3 PCT/EP2011/071360 EP2011071360W WO2012072670A3 WO 2012072670 A3 WO2012072670 A3 WO 2012072670A3 EP 2011071360 W EP2011071360 W EP 2011071360W WO 2012072670 A3 WO2012072670 A3 WO 2012072670A3
Authority
WO
WIPO (PCT)
Prior art keywords
extract
relates
chosen
xanthine base
slimming
Prior art date
Application number
PCT/EP2011/071360
Other languages
French (fr)
Other versions
WO2012072670A2 (en
Inventor
Albert Duranton
Original Assignee
L'oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by L'oreal filed Critical L'oreal
Publication of WO2012072670A2 publication Critical patent/WO2012072670A2/en
Publication of WO2012072670A3 publication Critical patent/WO2012072670A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4953Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/06Preparations for care of the skin for countering cellulitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59Mixtures
    • A61K2800/592Mixtures of compounds complementing their respective functions
    • A61K2800/5922At least two compounds being classified in the same subclass of A61K8/18

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to the use of a combination of at least two active principles chosen from (i) a lotus extract, (ii) a pomegranate (Punica granatum) extract and (iii) a xanthine base chosen from caffeine, theophylline, theobromine and paraxanthine, or a plant extract rich in xanthine base, as slimming agent. It also relates to a cosmetic treatment method for preventing or reducing the increase in the volume of adipose tissue and/or the formation of fatty lumps.
PCT/EP2011/071360 2010-12-03 2011-11-30 Use of a slimming combination WO2012072670A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR1060078A FR2968213B1 (en) 2010-12-03 2010-12-03 USE OF A SLIMMING ASSOCIATION
FR1060078 2010-12-03
US45704210P 2010-12-15 2010-12-15
US61/457,042 2010-12-15

Publications (2)

Publication Number Publication Date
WO2012072670A2 WO2012072670A2 (en) 2012-06-07
WO2012072670A3 true WO2012072670A3 (en) 2013-07-11

Family

ID=44202034

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2011/071360 WO2012072670A2 (en) 2010-12-03 2011-11-30 Use of a slimming combination

Country Status (2)

Country Link
FR (1) FR2968213B1 (en)
WO (1) WO2012072670A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1022293B1 (en) 2012-11-21 2016-03-14 Wendy Angrave METHOD AND COMPOSITIONS TO REMOVE TOXINES FROM THE BODY
US20160354303A1 (en) * 2014-02-11 2016-12-08 Elc Management Llc Method, Compositions, And Kit For Modulating The Appearance Of Volume On Keratin Surfaces
WO2018048892A1 (en) * 2016-09-07 2018-03-15 Isp Investments Llc Method for increasing lipolysis using a composition comprising bioactive nelumbo nucifera (lotus) extract
FR3087339A1 (en) * 2018-10-22 2020-04-24 Nexira COMPOSITION FOR TREATING OVERWEIGHT AND / OR OBESITY
TW202227085A (en) * 2020-09-14 2022-07-16 美商萊罕製藥股份有限公司 Deuterated paraxanthine and uses thereof
WO2023009681A1 (en) * 2021-07-27 2023-02-02 Ingenious Ingredients, LP Paraxanthine-based caffeine substitute compositions and method of use thereof in slow caffeine metabolizers

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2571256A2 (en) * 1984-07-20 1986-04-11 Chicouri Marcel New ointment having an action against cellulite
CN1166337A (en) * 1996-05-28 1997-12-03 方冬生 Weight-reducing tea
JP2004224789A (en) * 2002-11-29 2004-08-12 Nonogawa Shoji Kk Fat decomposition accelerator
US20070009474A1 (en) * 2005-07-08 2007-01-11 The Procter & Gamble Company Personal care compositions and methods for the beautification of mammalian skin and hair
WO2010054470A1 (en) * 2008-11-17 2010-05-20 Northern Innovations And Formulations Corp. Pumpkin and rose hips weight loss composition

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU86934A1 (en) 1987-06-30 1989-03-08 Oreal COSMETIC COMPOSITION HAVING ANTI-CELLULITIS AND AMIN-CISSING ACTION, THE ACTIVE INGREDIENT OF WHICH IS A 1-HYDROXYALKYLXANTHINE
LU87390A1 (en) 1988-11-17 1990-06-12 Oreal USE OF ALPHA-TOCOPHEROL NICOTINATE AND / OR HEXYL NICOTINATE IN A COSMETIC COMPOSITION WITH SLIMMING ACTION
FR2669537B1 (en) 1990-11-28 1993-02-19 Oreal SLIMMING COMPOSITION BASED ON ALPHA-2-BLOCKERS.
EP1762234A4 (en) 2004-06-28 2010-05-05 Kao Corp Ampk activator
KR100681439B1 (en) 2005-10-10 2007-02-15 박창은 Anti-diabetic and anti-obesity preparation
WO2010036613A1 (en) 2008-09-26 2010-04-01 Merck Sharp & Dohme Corp. Novel cyclic benzimidazole derivatives useful anti-diabetic agents

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2571256A2 (en) * 1984-07-20 1986-04-11 Chicouri Marcel New ointment having an action against cellulite
CN1166337A (en) * 1996-05-28 1997-12-03 方冬生 Weight-reducing tea
JP2004224789A (en) * 2002-11-29 2004-08-12 Nonogawa Shoji Kk Fat decomposition accelerator
US20070009474A1 (en) * 2005-07-08 2007-01-11 The Procter & Gamble Company Personal care compositions and methods for the beautification of mammalian skin and hair
WO2010054470A1 (en) * 2008-11-17 2010-05-20 Northern Innovations And Formulations Corp. Pumpkin and rose hips weight loss composition

Also Published As

Publication number Publication date
WO2012072670A2 (en) 2012-06-07
FR2968213A1 (en) 2012-06-08
FR2968213B1 (en) 2014-03-21

Similar Documents

Publication Publication Date Title
WO2012072670A3 (en) Slimming compositions
WO2011027085A3 (en) Active principle from candida saitoana, and cosmetic use thereof for detoxifying skin cells
WO2009101503A3 (en) Use of natural active substances in cosmetic or therapeutic compositions
WO2013105048A3 (en) New use of zerumbone and compositions comprising zerumbone
WO2012030984A3 (en) Skin compositions and methods of use thereof
EP3147285A3 (en) Purinone compounds as kinase inhibitors
WO2012042224A3 (en) Pharmaceutical composition comprising deferasirox
WO2012075383A3 (en) Bromodomain inhibitors and uses thereof
HK1243630A1 (en) Dermal pharmaceutical compositions of 1-methyl-2',6'-pipecoloxylidide and method of use
WO2011051633A3 (en) Use of a punica granatum extract to fight against the whitening of the hair
WO2011123719A3 (en) Use of faah inhibitors for treating abdominal, visceral and pelvic pain
WO2011149981A3 (en) Oral formulations for counteracting effects of aging
WO2014026804A3 (en) Agent and method for the temporary deformation of keratin fibres
WO2014083422A3 (en) Treating soluble coffee
WO2012007214A3 (en) Hair-conditioning compositions
EP4233896A3 (en) Method for preparing an immunogenic lysate, the lysate obtained, dendritic cells loaded with such lysate and a pharmaceutical composition comprising the lysate or the dendritic cells
WO2010098596A3 (en) Cosmetic composition for skin moisturisation comprising pine-resin extract, pinus densiflora needle extract and pinus densiflora root extract
WO2012161497A3 (en) Peptide derivatives having a superior moisturizing effect and uses thereof
IN2014MN02269A (en)
WO2012045974A3 (en) Cosmetic use of a tropaeolum majus extract as an active principle for promoting the oxygenation of skin tissue
WO2014027981A3 (en) Effervescent tablet formulations of dapoxetine and a pde5 inhibitor
SG10201908690WA (en) Novel method of use and compositions
EP2898891A3 (en) Terminalia chebula and Terminalia bellerica extracts for inhibition of xanthine oxidase
WO2011113785A3 (en) A cosmetic composition for rejuvenating skin appearance
WO2014023649A3 (en) Dermal cosmetic compositions having osmoprotecting activity

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11796940

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 11796940

Country of ref document: EP

Kind code of ref document: A2